| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.003 |